CATALOGO DEI PRODOTTI DELLA RICERCA

CETTO, Gianluigi
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.466
EU - Europa 7.486
AS - Asia 5.256
SA - Sud America 753
AF - Africa 109
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 6
Totale 22.089
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.359
RU - Federazione Russa 2.482
SG - Singapore 2.289
GB - Regno Unito 1.600
CN - Cina 1.580
IT - Italia 727
SE - Svezia 613
BR - Brasile 599
FR - Francia 471
IE - Irlanda 446
FI - Finlandia 438
VN - Vietnam 395
HK - Hong Kong 391
DE - Germania 370
KR - Corea 165
UA - Ucraina 112
IN - India 85
CA - Canada 59
TR - Turchia 51
BD - Bangladesh 50
AR - Argentina 49
JP - Giappone 41
BE - Belgio 38
IR - Iran 32
MX - Messico 32
ES - Italia 30
NL - Olanda 29
IQ - Iraq 25
NG - Nigeria 25
ZA - Sudafrica 25
PL - Polonia 23
EC - Ecuador 21
IL - Israele 21
ID - Indonesia 19
UZ - Uzbekistan 18
CO - Colombia 17
MA - Marocco 17
VE - Venezuela 17
LT - Lituania 16
PK - Pakistan 16
CL - Cile 14
EG - Egitto 14
AT - Austria 13
PY - Paraguay 13
AU - Australia 10
NP - Nepal 10
CH - Svizzera 9
CZ - Repubblica Ceca 9
SA - Arabia Saudita 9
UY - Uruguay 9
AL - Albania 8
LV - Lettonia 8
RO - Romania 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 6
JO - Giordania 6
PE - Perù 6
PH - Filippine 6
BO - Bolivia 5
BY - Bielorussia 5
PT - Portogallo 5
SN - Senegal 5
AM - Armenia 4
ET - Etiopia 4
EU - Europa 4
JM - Giamaica 4
KE - Kenya 4
MY - Malesia 4
TW - Taiwan 4
AO - Angola 3
DK - Danimarca 3
GR - Grecia 3
GY - Guiana 3
KG - Kirghizistan 3
NO - Norvegia 3
PS - Palestinian Territory 3
RS - Serbia 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
TN - Tunisia 3
BG - Bulgaria 2
BH - Bahrain 2
DZ - Algeria 2
EE - Estonia 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
KW - Kuwait 2
ML - Mali 2
NI - Nicaragua 2
OM - Oman 2
PW - Palau 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
Totale 22.074
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.418
Southend 1.350
Singapore 1.181
Chandler 801
Moscow 772
Ashburn 722
San Jose 704
Dallas 605
Woodbridge 446
Dublin 445
Hong Kong 382
Ann Arbor 296
Houston 288
The Dalles 240
Council Bluffs 222
Beijing 206
Verona 199
Lawrence 163
Princeton 163
New York 161
Wilmington 153
Los Angeles 152
Ho Chi Minh City 146
Nanjing 119
Jinan 115
Shenyang 109
Buffalo 95
Hanoi 94
Hebei 89
Milan 82
Tianjin 81
Helsinki 79
São Paulo 63
Orem 56
Zhengzhou 53
Ningbo 51
Boardman 49
Santa Clara 45
Haikou 44
Nanchang 44
Hangzhou 43
Changsha 42
Sindelfingen 41
Munich 38
Brussels 37
Chennai 37
Tokyo 37
Taizhou 34
Redondo Beach 33
Jiaxing 31
Turku 31
Guangzhou 30
Lancaster 27
Rio de Janeiro 27
Chicago 26
Montreal 25
Norwalk 25
Abuja 24
Columbus 24
Seattle 24
Falls Church 23
Fairfield 22
Rome 22
Brooklyn 21
Taiyuan 21
Amsterdam 19
Da Nang 19
Fuzhou 19
Mexico City 17
Philadelphia 17
Warsaw 17
Denver 16
London 16
Tashkent 16
Frankfurt am Main 15
Manchester 15
Phoenix 15
Toronto 15
Atlanta 14
Belo Horizonte 13
Istanbul 13
Lanzhou 13
San Francisco 13
Stockholm 13
Boston 12
Brasília 12
Kent 12
Parma 12
Falkenstein 11
Guarulhos 11
Johannesburg 11
Poplar 11
Curitiba 10
Haiphong 10
Kyiv 10
Campinas 9
Dearborn 9
Madrid 9
Thái Nguyên 9
Auburn Hills 8
Totale 13.689
Salva come PNG Salva come JPEG
Nome #
Il Formestone (4-Idrossiandrostenedione-LentaronR) nel trattamento di pazienti con cr. mammario metastatico. 297
Acute lymphoblastic leukaemia after radiotherapy and adjuvant chemotherapy (CMF) for breast cancer. 259
[Lung diseases during the course of systemic diseases: current clinico-radiological problems (proceedings)] 244
Anti PSCA Monoclonal Antibody and scFv-Fragment for Immunotherapy of Prostate, Pancreatic and Bladder Carcinoma 238
Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events 237
Characterization of a new anti PSCA monoclonal antibody and scFv fragment for diagnosis and immunotherapy of prostate, pancreatic and bladder carcinoma. 229
Significato prognostico dell'indice di proliferazione cellulare nel carcinoma mammario. 228
Pseudomonas septicaemia. A review of 60 cases observed in a university hospital 224
Renal toxicity and osteonecrosis of the jaw in cancer patients treated with bisphosphonates: a long-term retrospective analysis. 223
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 221
A feasibility study for an hospital-based breast cancer registry. 211
Gamma Knife radiosurgery in brain metastases from testicular tumors 210
Production of a biotinylated anti-PSMA single-chain antibody fragment (scFv) for imaging and radioimmunotherapy 208
bcl-2 but not p53 expression is associated with resistance to chemotherapy in advanced breast cancer 207
Analisi di linkage in famiglie con carcinoma mammario ereditario. 203
Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity 201
A phase II study of induction chemotherapy with gemcitabine (G) and cisplatin (P) in locally advanced non-small cell lung cancer: interim analysis 201
Combination of chemotherapy and radiotherapy improves the cure rate in primary extranodal lymphomas of the head and neck (PLHN) 199
Chirurgia e chemioterapia nel trattamento dei linfomi gastrici primitivi: revisione casistica 195
Ingegnerizzazione di un vettore per espressione di frammenti anticorpali (scFv) biotinilati in procarioti, purificazione ed analisi funzionale 194
Analisi immunoistochimica per la ricerca di micrometastasi osteo midollari nel carcinoma mammario. 188
Primary extranodal lymphomas of Waldeyer's ring, stage IE and IIE: Long-term survival after chemotherapy combined with radiotherapy 187
Monoterapia empirica con ceftazidime nelle infezioni di pazienti neutropenici affetti da emopatie maligne 187
Postoperative chemotherapy increases the disease-free survival rate in primary gastric lymphomas stage IE and IIE 186
Current trends in hematopoietic stem cell transplantation in Europe 183
Establishment and characterization of a new human melanoma cell line (HU 214) with a high growth potential and stable properties 183
Produzione e validazione preclinica di un anticorpo anti-PSMA per diagnostica ed immunotargeting 183
[Idiopathic aneurysm of the right ventricle. Report of a case] 182
Estrogen receptors in 699 primary breast cancers: a comparison of immunohistochemical and biochemical methods. 182
Generazione di nuovi anticorpi anti prostate stem cell antigen (PSCA) e loro caratterizzazione al fine di un futuro utilizzo nella terapia e nella diagnosi dei carcinomi prostatico, pancreatico e della vescica 178
Attività proliferativa del carcinoma mammario: studio su 329 pazienti. 176
Anemia, cancro e chemioterapia antiblastica. 171
Detection of normal and malignant megakaryocytes by anti beta-thromboglobulin serum. An immunofluorescence study 170
Comportamento dell'ACE e del CEA in pazienti affetti da carcinoma polmonare. 170
Anemia, cancro e chemioterapia antiblastica. 170
Terminal transferase expression in relapsed acute myeloid leukaemia 169
A phase II study of gemcitabine (GEM) and vindesine (VDS) in elderly or poor performance patients with unresectable non small cell lung cancer (NSCLC): final results. 169
Attività di un Registro Tumori di Patologia Mammaria su base ospedaliera. 169
A good death for cancer patients:still a dream? 167
Cytofluorymetric evaluation of DNA ploidy in lung cancer: a broncoscopic study 167
Cisplatin pharmacokinetics in elderly patients 166
Virtual colonoscopy in the surveillance of suspected HNPCC carriers: a preliminary study 166
Caratterizzazione di una nuova linea cellulare di melanoma umano. 165
Adjuvant chemotherapy with high dose epirubicin and cyclophosphamide (EC) vs cyclophosphamide, methotrexate, fluorouracil (CMF) in high risk premenopausal breast cancer patients. 97. 165
Clinical evaluation of 51 patients with small cell lung cancer (SCLC). 164
Immuno-histological analysis of bone marrow involvement in lymphoproliferative disorders 163
Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients 161
The detection of breast cancer (b.c.) cells in bone marrow (b.m.): comparative analysis of sensitivity and specificity of three different methods. 159
Pathological,biological and clinical characteristics and surgical mamagement of ederly women with brest cancer 158
High pathological response rate in locally advanced esophageal cancer after neoadjuvant combined modality therapy: dose finding of a weekly chemotherapy schedule with protracted venous infusion of 5-fluorouracil and dose escalation of cisplatin, docetaxel and concurrent radiotherapy. 158
Comparative analysis of three different methods in detecting breast cells in bone marrow. 158
Analisi puntiforme dei valori sierici del CA 15.3 e del CEA in pazienti con carcinoma della mammella. 157
Use of the ratio of time to progression following first and second line therapy to document the activity of the combination of oxaliplatin with 5-fluorouracil in the treatment of colorectal carcinoma 156
Prognostic significance of estrogen receptors in 405 primary breast cancers: a comparison of immunohistochemical and biochemical methods 155
Comparative analysis of three different techniques in detecting breast cancer (b.c.) cells in bone marrow (b.m.). 155
Gram-negative septicemia in patients with hematologic malignancies 154
Cation content and membrane deformability of heterozygous beta-thalassaemic red blood cells 153
Cisplatin pharmacokinetics using a five-day schedule during repeated courses of chemotherapy in germ cell tumors 153
Adjuvant chemotherapy with high-dose epirubicin and cyclophosphamide vs CMF in high-risk premenopausal breast cancer patients (pts). Prospective randomized phase III trial. 153
Comportamento del CA 15 3 nelle pazienti affette da carcinoma mammario (stadio I III). 153
Bone marrow micrometastases in 109 breast cancer patients: correlations with clinical and pathological features and prognosis 149
Ricerca immunoistochimica di micrometastasi osteo midollari in 33 pazienti portatrici di carcinoma della mammella. 149
Efficacy of chemotherapy in two cases of extranodal retroperitoneal germ cell tumors. 148
Correlazione tra trattamento adiuvante (chemioterapia e/o ormonoterapia), dosaggio RE e RPg, N , comparsa di metastasi in 150 pazienti con carcinoma mammario. 146
Estramustine plus docetaxel as second-line therapy in patients with hormone-refractory prostate cancer resistant to docetaxel alone 144
Caratterizzazione fenotipica di cloni ottenuti da una linea cellulare di melanoma umano. 143
Comparison of two different methods for the determination of estrogen receptors (ER) in breast cancer (b.c.). 143
Adjuvant chemotherapy with high dose epirubicin and cyclophosphamide (ec) vs cyclophosphamide, methotrexate, fluorouracil (CMF) in high risk premenopausal breast cancer patients (PTS). A prospective randomized trial. E 143
Positive immunostaining with MLuC1 of bone marrow aspirate predicts poor outcome in patients with small-cell lung cancer 142
Dosaggio della NSE in pazienti affetti da tumori di origine neuroectodermica. 142
Fanconi's anaemia in adults: study of three families 140
Evoluzione del concetto di dose in chemioterapia: basi teoriche e modelli matematici. Cetto G.L., Molino A. in: “L’intensità di dose in Oncologia Medica”. G.Bonadonna, G.Robustelli della Cuna eds., Edimes, Progressi in Oncologia Clinica 4: pag. 11-22, Pavia 1995 138
Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer 136
Gemcitabine and continuous infusion of 5-fluorouracil in locally advanced and metastatic pancreatic cancer: a phase I-II study 135
La terapia ad alte dosi nel carcinoma mammario metastatico e nella mastite carcinomatosa. 135
Phase I°/II° trial of recombinant alfha 2 interferon (IFN) and Vinblastine (VBL) in metastatic renal cell cancer (MRCC). 134
Efficacia antiemetica dell'ondansetron (GR 38032): continuità dell'attività terapeutica. 130
The antiemetic activity of high dose metoclopramide and high dose alizapride in combination with lorazepam in patients receiving chemotherapy 129
Gemcitabine (GEM) and Vindesine (VDS) in advanced non-small cell lung cancer (NSCLC): A phase II study in elderly or poor performance status patients 128
Micrometastasi midollari in pazienti con carcinoma mammario operabile: studio su 51 casi. 126
Bone marrow micrometastases in breast cancer patients. 126
Replicative fraction in breast carcinoma. An Immunohistochemical study of 236 cases. 125
Bone metastases from primary cardiac sarcoma: case report 125
Ki-67 e risposta alla chemioterapia nel carcinoma mammario avanzato. 122
Correlation of replicative fraction by Ki67 immunohistochemistry (RF) with clinico pathological features and prognosis in breast cancer (B.C.). 120
Detection of a soluble form of the receptor for interleukin 2 in the serum of patients with hairy cell leukaemia 119
Chemotherapy for metastatic melanoma 119
Ifosfamide encephalopathy: a case report 119
Estrogen and progesterone receptors in breast cancer: correlation with clinical and pathological features and with prognosis. 119
New standards in the chemotherapy of metastatic hormone-refractory prostate cancer 118
Economic aspect of high-dose-chemotherapy (HDC): a clinician’s perspective review 118
Significato Prognostico dei recettori per estrogeni (RE) e per progesterone (RP) nel cancro mammario. 118
Leucemia linfatica acuta dopo radioterapia e chemioterapia adiuvante (CMF) per cr della mammella. 117
Micrometastases in bone marrow: study in 51 breast cancer patients. 117
Neo-adjuvant chemotherapy in non-smallcell lung cancer (SSCLC) 116
Estrogen receptors in 699 primary breast cancers: a comparison of immunohistochemical and biochemical methods. 116
Micrometastases in bone marrow in breast cancer patients. 115
Identification of Clinical Prognostic Factors in Patients with Unknown Primary Tumors Treated with a Platinum-Based Combination 113
Comparison of two different methods of evaluating proliferative index in breast cancer. 113
Kinetic of cisplatin in a five day schedule during repetitive courses of chemotherapy. 112
Totale 16.285
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.143
article - articoli 30.628
book - libri 3.019
conference - conferenze 37.496
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 142.286
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202136 0 0 0 0 0 0 0 0 0 0 0 36
2021/20221.469 76 457 13 204 78 37 33 76 64 31 127 273
2022/20232.534 203 216 270 361 345 624 23 141 269 18 45 19
2023/20241.043 39 114 89 113 146 150 39 39 5 48 168 93
2024/20253.050 179 216 96 489 148 56 163 106 508 220 211 658
2025/20268.074 637 529 558 1.372 2.005 459 714 392 664 421 81 242
Totale 22.150